glp 1 agonist dosing Glucagon-like peptide-1 receptor agonists (GLP-1 RA): dosing, dose GLP-1 receptor agonists and beyond.
Description
A significant reduction in appetite and food intake was also observed with tirzepatide compared to placebo in people with T2D [45]
Several different GLP-1 medications are approved specifically for weight loss, including Wegovy, Saxenda, and Zepbound
They provide an estimate of equivocal dosages to minimize the risk of underdosing or overdose, maximize efficacy, and reduce GI side effects
Results from the 40-week phase 3 ACHIEVE-1 trial in participants with obesity and poorly controlled T2D shows mean weight loss of 4.7%, 6.1%, 7.9% and 1.6% for groups receiving 3 mg, 12 mg, 36 mg, and placebo, respectively (48)
These events were dose-dependent, primarily of mild to moderate severity, and were partially alleviated by lower initial doses (2 mg vs
